Green Tea in Breast Cancer Patients
कीवर्ड
सार
खजूर
| अंतिम सत्यापित: | 02/28/2018 |
| पहले प्रस्तुत किया गया: | 07/28/2009 |
| अनुमानित नामांकन प्रस्तुत किया गया: | 07/29/2009 |
| पहले पोस्ट किया गया: | 07/30/2009 |
| अंतिम अद्यतन प्रस्तुत किया: | 03/27/2018 |
| अंतिम अद्यतन पोस्ट: | 03/29/2018 |
| वास्तविक अध्ययन प्रारंभ दिनांक: | 05/06/2008 |
| अनुमानित प्राथमिक समापन तिथि: | 12/13/2010 |
| अनुमानित अध्ययन पूर्णता तिथि: | 06/05/2016 |
स्थिति या रोग
हस्तक्षेप / उपचार
Dietary Supplement: tea capsules
चरण
शाखा समूह
| बांह | हस्तक्षेप / उपचार |
|---|---|
| Active Comparator: tea capsules 3 tea capsules daily for 3 weeks | Dietary Supplement: tea capsules 3 tea capsules daily for 3 weeks |
| No Intervention: Control No tea capsules |
पात्रता मापदंड
| युग अध्ययन के लिए पात्र | 18 Years सेवा 18 Years |
| सेक्स अध्ययन के लिए पात्र | Female |
| स्वस्थ स्वयंसेवकों को स्वीकार करता है | हाँ |
| मानदंड | Inclusion Criteria: - Postmenopausal (at least 2 years since last menstrual period) or age 55 or older if prior hysterectomy - Non-current (not with past 6 months) user of menopausal hormones - Mammographic abnormality consistent with any type of incident breast cancer necessitating a diagnostic biopsy (BIRAD IV(b), (c) or V) will be sufficient to draw baseline LFT and complete screening questionnaire. Unless the biopsy confirms incident breast cancer, such subjects will not be included in further research interventions and they will not serve as EGCG treated or control subjects. - Diagnosed with incident breast cancer on the diagnostic biopsy is required for inclusion in the EGCG or control treatment groups. - Non-green tea drinker (less than monthly) - this criteria does not apply to black tea or herbal tea - Provided written informed consent Exclusion Criteria: - Green tea drinker (once per month or more) - History of breast cancer or other cancer including a prior diagnosis of any type of incident breast cancer. - Known allergy to tea - Abnormal liver enzymes (plus or minus 10% of the normal ranges). |
परिणाम
प्राथमिक परिणाम उपाय
1. level of reduction in proliferation or increase in apoptosis in association with short-term EGCG [At surgery]
